BEIGENE (06160.HK) issued 0.2147 million shares due to the vesting of restricted share units.
Gelonghui reported on April 30 that BEIGENE (06160.HK) announced that on April 29, 2025, it will issue 0.2147 million ordinary shares due to the vesting of restricted stock units granted under the equity plan (excluding company Directors).
BEIGENE (06160) won the patent dispute in the USA as the USPTO ruled that the Pharmacyclics patent is invalid.
BEIGENE (06160) announced that the USPTO made a final written decision regarding Phar...
BEIGENE's revenue growth in 2024, narrowing losses, and core products gaining global traction.
① The company achieved a revenue of 27.214 billion yuan for the year, with a year-on-year increase of 56.19%; the net income attributable to shareholders was -4.978 billion yuan, a decrease of 17.38% from the previous year; the net income excluding non-recurring items was -5.379 billion yuan, a year-on-year decrease of 17.38%; ② The revenue share of Baiyueze and Baizean continues to expand, driving the company's revenue growth.
BeiGene Ltd. Successfully Passes Key Resolutions at EGM
BEIGENE (688235.SH) released its performance for the year 2024, with revenue of 27.214 billion yuan, a year-on-year increase of 56.19%.
BEIGENE (688235.SH) released its annual report for 2024, with the revenue for the year 2024 being 27...
Express News | RBC Capital Reiterates Outperform on BeiGene, Maintains $312 Price Target
